Intel
INTC
Oracle
ORCL
Netflix
NFLX
4
Meta Platforms
META
5
Apple
AAPL
US Stock MarketDetailed Quotes
CLYM Climb Bio
- 1.230
- -0.040-3.15%
Close Apr 28 16:00 ET
- 1.230
- 0.0000.00%
Post 16:05 ET
83.12MMarket Cap-0.80P/E (TTM)
1.310High1.200Low58.02KVolume1.260Open1.270Pre Close71.47KTurnover0.19%Turnover RatioLossP/E (Static)67.58MShares10.86052wk High0.39P/B37.81MFloat Cap1.05052wk Low--Dividend TTM30.74MShs Float29.690Historical High--Div YieldTTM8.66%Amplitude1.050Historical Low1.231Avg Price1Lot Size
About Climb Bio Company
Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wellesley Hills, MA.
Company Profile
SymbolCLYM
Company NameClimb Bio
Listing DateAug 10, 2021
Issue Price12.50
Founded2018
CEODr. Stephen Thomas, PhD
MarketNASDAQ
Employees18
Fiscal Year Ends12-31
Address20 William Street,Suite 145
CityWellesley Hills
ProvinceMassachusetts
CountryUnited States of America
Zip Code02481-4103
Phone1-866-857-2596
Websitehttp://www.climbbio.com
Company Executives
- Name
- Position
- Salary
- Dr. Stephen Thomas, PhD
- Interim Chief Executive Officer and Director
- --
- Dr. Aoife M. Brennan, M.B.
- President, Chief Executive Officer and Director
- --
- Emily Pimblett
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Dr. Brett Kaplan, M.D.
- Chief Operating Officer and Principal Financial Officer
- --
- Dr. Douglas E. WilliaPhD
- Chairman of the Board
- --
- Dr. Andrew Levin, M.D.,PhD
- Chairman of the Board
- 87.91K
- Stephen Thomas
- Director
- --
- Kimberlee Drapkin
- Director
- --
- Alexander Cumbo
- Director
- --
- Dr. Liam Ratcliffe, M.B.A.,PhD
- Lead Independent Director
- 71.33K
- Dr. Judith A. Dunn, PhD
- Independent Director
- 69.66K
- Adam Rosenberg
- Independent Director
- 77.16K
- Dr. Jan L. Hillson, M.D.
- Senior Clinical Advisor
- --
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call